In familial pancreatic cancer (FPC), CDKN2A mutations, along with those in BRCA2 and PALB2, were prevalent, particularly in FPC probands, highlighting their significance in hereditary pancreatic cancer [43]. Here, CDKN2A is linked to pancreatic neoplasm.